Cite

HARVARD Citation

    Weidemann, F. et al. (n.d.). Long‐term outcome of enzyme‐replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. Journal of internal medicine. pp. 331-341. [Online]. 
  
Back to record